Engala, Jeffrey L.
HRN: 21-87-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2022
CEFUROXIME 750MG (VIAL)
09/03/2022
09/09/2022
IVT
750mg
Q8hrs
AGE With Mod DHN;PCAP B
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes